SpineThera develops novel, sustained-release, injectable drugs to treat pain; offering patients and physicians alternatives that reduce risk, improve outcomes, and manage overall treatment costs in markets with few or no approved drugs.
It was founded in 2012 and is headquartered in Plymouth, Minnesota.